Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Hamilton-Craig I, Kostner K, Colquhoun D, Woodhouse S.

Vasc Health Risk Manag. 2010 Nov 10;6:1023-37. doi: 10.2147/VHRM.S13496. Review.

PMID:
21127699
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
[PubMed - indexed for MEDLINE]
3.

Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.

PMID:
18485273
[PubMed - indexed for MEDLINE]
Free Article
5.

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, Trip MD, Eriksson M, Visseren FL, Schaefer JR, Kastelein JJ; Triple Study Group.

Clin Ther. 2010 Apr;32(4):615-25. doi: 10.1016/j.clinthera.2010.04.014.

PMID:
20435231
[PubMed - indexed for MEDLINE]
7.

Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy.

González CA, Rubio-Guerra AF, Pavía A, Redding FJ, Cervantes JL, Zacarías JL, Yza R, Carranza J, Fernández P, Morales E, Robles FJ, Leyva JL, Rodríguez L.

Clin Drug Investig. 2007;27(5):333-7.

PMID:
17451281
[PubMed - indexed for MEDLINE]
8.

Clinical use of ezetimibe.

Cheng AY, Leiter LA.

Can J Clin Pharmacol. 2003 Winter;10 Suppl A:21A-5A. Review.

PMID:
14571302
[PubMed - indexed for MEDLINE]
9.

Ezetimibe.

Darkes MJ, Poole RM, Goa KL.

Am J Cardiovasc Drugs. 2003;3(1):67-76; discussion 77-8. Review.

PMID:
14727947
[PubMed - indexed for MEDLINE]
10.

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial.

Yu CC, Lai WT, Shih KC, Lin TH, Lu CH, Lai HJ, Hanson ME, Hwang JJ.

BMC Res Notes. 2012 May 23;5:251. doi: 10.1186/1756-0500-5-251.

PMID:
22621316
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.

Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E; Ezetimibe Study Group.

Am Heart J. 2004 Sep;148(3):447-55.

PMID:
15389231
[PubMed - indexed for MEDLINE]
12.

Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.

Gotto AM Jr, Farmer JA.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):664-72. Review.

PMID:
17122799
[PubMed - indexed for MEDLINE]
13.

Ezetimibe: a selective cholesterol absorption inhibitor.

Nutescu EA, Shapiro NL.

Pharmacotherapy. 2003 Nov;23(11):1463-74. Review.

PMID:
14620392
[PubMed - indexed for MEDLINE]
14.

Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.

Bissonnette S, Habib R, Sampalis F, Boukas S, Sampalis JS; Ezetrol Add-On Investigators.

Can J Cardiol. 2006 Oct;22(12):1035-44. Erratum in: Can J Cardiol. 2007 Feb;23(2):159.

PMID:
17036098
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor.

Lipka LJ.

Cardiovasc Drug Rev. 2003 Winter;21(4):293-312. Review.

PMID:
14647533
[PubMed - indexed for MEDLINE]
16.

Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.

Elis A, Zhou R, Stein EA.

Am J Cardiol. 2011 Jul 15;108(2):223-6. doi: 10.1016/j.amjcard.2011.03.027. Epub 2011 May 3.

PMID:
21545982
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.

Derosa G, D'Angelo A, Franzetti IG, Ragonesi PD, Gadaleta G, Scalise F, Ciccarelli L, Piccinni MN, Cicero AF.

J Clin Pharm Ther. 2009 Jun;34(3):267-76.

PMID:
19650249
[PubMed - indexed for MEDLINE]
18.

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.

Morrone D, Weintraub WS, Toth PP, Hanson ME, Lowe RS, Lin J, Shah AK, Tershakovec AM.

Atherosclerosis. 2012 Aug;223(2):251-61. doi: 10.1016/j.atherosclerosis.2012.02.016. Epub 2012 Feb 16. Review.

PMID:
22410123
[PubMed - indexed for MEDLINE]
19.

Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.

Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL.

Curr Med Res Opin. 2007 Aug;23(8):2009-26.

PMID:
17659159
[PubMed - indexed for MEDLINE]
20.

Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery disease.

Genest J.

Can J Cardiol. 2006 Aug;22(10):863-8. Review.

PMID:
16957804
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk